Professionals from leading companies in the Life Sciences sector came together for a new edition of Ambit Meets: Tech Trends & Compliance in Life Science, the annual event organized by Ambit Iberia to share experiences, analyze trends, and discuss the challenges that will shape the future of the industry.
The event brought together key stakeholders from different departments at a particularly significant moment for the sector. Digital transformation, the rise of artificial intelligence, and the evolution of the European regulatory framework were at the center of many discussions, with a common goal: understanding how to innovate while maintaining the levels of quality, traceability, and compliance required by the industry.
Throughout the event, the strategic importance of the pharmaceutical sector was highlighted as one of the main drivers of industry and innovation in Spain and Europe, as well as the need to attract and develop talent capable of leading the next stage of technological transformation.
One of the highlights of the day was the panel discussion “Operational Challenges and Scaling in the Pharma Industry”, featuring Juan Ignacio Alonso from Andersen, Jorge Castro from Applus+ Laboratories, Amaia Eguiazabal from EasyVista, Gerardo Barbosa from Multiplica, Marc Ramoneda from Appliant, and Unai Sancho from Agilent Technologies. The panelists shared insights on business growth, process digitalization, operational efficiency, and change management in organizations that must balance innovation with regulatory demands.
A practical perspective was provided by Cinfa, which presented a real-world case focused on the automation of its production plant in Pamplona. The company shared its experience implementing new industrial technologies, the challenges encountered during the process, and the impact automation is having on the plant’s efficiency and production capacity.
Artificial intelligence also played a leading role throughout the event. The panel discussion “AI in Healthcare & Pharma: From Potential to Regulatory Control” brought together Alfred Opisso from Roche, Francesc Paradell from Meribel Pharma, Christian Gay from Aizon, and Oriol Valls from Merck. The discussion explored both the opportunities AI offers to accelerate processes and improve decision-making, as well as the challenges associated with model validation, data governance, human oversight, and compliance with the new regulatory requirements currently being developed in Europe.
In addition to the panel discussions, attendees took part in a collaborative workshop where they shared the priorities, barriers, and expectations that currently exist within their organizations regarding digital transformation. The goal was to build a collective and realistic view of the sector’s current state, identifying both the initiatives that generate the greatest consensus and the areas that continue to present significant challenges.
A common theme emerged throughout the day: technology will continue to play a fundamental role in the evolution of the pharmaceutical industry, but its success will depend on organizations’ ability to integrate it responsibly, securely, and in alignment with the quality principles that define the sector.
At Ambit Iberia, we would like to express our sincere gratitude to all the people and organizations who made this edition of Ambit Meets possible.
We would especially like to thank the event sponsors, Spertoo and ValGenesis, for their trust and support, which are essential to continuing to foster our space for networking, learning, and collaboration within the Life Sciences ecosystem.
We would also like to thank all the speakers and participants who shared their expertise and knowledge throughout the event. Their contributions enriched the discussions and helped provide a diverse perspective on the challenges and opportunities currently facing the sector.
A special acknowledgment goes to Cinfa for sharing its experience and presenting attendees with a real-world example of industrial transformation.
We would also like to thank those who hosted, moderated, and facilitated the various sessions, encouraging open and engaging conversations among all participants.
And, of course, thank you to all the attendees for their participation, questions, and contributions. Your engagement once again made Ambit Meets a leading forum for sharing knowledge and collectively shaping the future of digital transformation in Life Sciences.
Thank you for being part of such a special event. We look forward to seeing you at the next edition, with much more to discover.
